Genentech
@poseida.com
Breakthrough science. One moment, one day, one person at a time.
Genentech's Company Logos
Genentech's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0B41CD
Denim
11, 65, 205
223, 90, 42
95, 68, 0, 20
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About Genentech
Poseida Therapeutics is a clinical-stage biopharmaceutical company that is dedicated to developing cell and gene therapies with the capacity to cure cancers and genetic diseases. They are committed to redefining treatment paradigms for life-threatening conditions and providing new hope to patients. Using their innovative genetic engineering technologies, Poseida Therapeutics aims to revolutionize the field of cell and gene therapies.
Their differentiated genetic engineering platforms include the non-viral piggyBac® DNA Delivery System and the Cas-CLOVER™ Site-Specific Gene Editing System, allowing them to insert genetic payloads and make accurate site-specific deletions, insertions, and knock-ins in multiple cell types. By focusing on specific cell populations, Poseida Therapeutics can potentially advance fully allogeneic CAR-T therapies and develop functional cures for rare genetic diseases. Their leadership team combines scientific expertise with strategic insight to drive innovation and deliver novel therapeutics.
With a commitment to transformative treatments, Poseida Therapeutics is poised to redefine therapies across genetic diseases and cancers
Company type
Public Company
Year founded
2014
Company size
201-500 employees
Related Brands
Tags
Cell therapy
Biopharmaceutical pipeline
Oncology therapeutics
Biotech platform technologies
